Highly selective mTOR inhibitors have been discovered through the exploration of the heteroaromatic ring engaging the binding affinity region in mTOR kinase. Compound11showed predicted BBB permeability in a MDCK-MDR1 permeabilityin vitroassay, being the first pyrimido-pyrrolo-oxazine with potential application in the treatment of neurological disorders.

Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR inhibitor with predicted blood-brain barrier permeability / C. Borsari, E. Keles, A. Treyer, M. De Pascale, P. Hebeisen, M. Hamburger, M.P. Wymann. - In: RSC MEDICINAL CHEMISTRY. - ISSN 2632-8682. - 12:4(2021 Apr), pp. 579-583. [10.1039/d0md00408a]

Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR inhibitor with predicted blood-brain barrier permeability

C. Borsari
Primo
;
2021

Abstract

Highly selective mTOR inhibitors have been discovered through the exploration of the heteroaromatic ring engaging the binding affinity region in mTOR kinase. Compound11showed predicted BBB permeability in a MDCK-MDR1 permeabilityin vitroassay, being the first pyrimido-pyrrolo-oxazine with potential application in the treatment of neurological disorders.
Settore CHIM/08 - Chimica Farmaceutica
apr-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
32_2021_RSC MedChem.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.92 MB
Formato Adobe PDF
1.92 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1016354
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact